For many pharmaceutical companies, it is becoming clearer that the development of new and original molecules is an extremely difficult task, incurring huge financial costs. An alternative approach involves the use of nanotechnology to improve the effectiveness of traditional medicines. Targeted delivery, high stability, prolonged release and many other advantages can be realized with the use of nanostructured drugs, whose effectiveness is many times greater than their molecular counterparts. 

The group is focused on synthesizing nano-drugs for various applications, studying their activity and toxicity, and conducting pre-clinical studies.

Lab news